Skip to main content
IMS Events Main banner
Back

    Surbhi Sidana, surbhi.sidana@stanford.edu

    Assistant Professor
    Stanford University, United States

    Dr. Surbhi Sidana is an Associate Professor of Medicine at Stanford University and specializes in the treatment of multiple myeloma and related disorders. She leads the Myeloma CAR-T/Immunotherapy program at Stanford University.

    Dr Sidana has an active, broad research portfolio that includes clinical trials of novel therapies in myeloma and related disorders, translational research, epidemiologic and patient reported outcome studies. She has a special focus on research with immunotherapies such as CAR-T cell therapy and bispecific antibodies. She has published over 80 research manuscripts.

    Dr Sidana is the Leader of the Myeloma Disease Focused Group and the Associate Director for Clinical Research in the BMT/ Cell Therapy Division at Stanford University. Dr Sidana Co-chairs the Quality-of-Life Committee of the International Myeloma Working Group. She is also the Vice-Chair of the American Society of Hematology Committee on Communications. She co-leads a multi-institutional collaboration on real world outcomes with immunotherapies in myeloma. She also a member of the ASH Editor Search Committee and the SWOG Myeloma Committee.



    Disclosure information not submitted.

    Presentation(s):